Clinical Trial Update: Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating Radium-223 dichloride in combination with hormone therapy and SBRT for metastatic prostate cancer. The study has posted results as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Androgen deprivation therapy (Androgen deprivation therapy)
• Stereotactic Body Radiation Therapy (SBRT)
• Xofigo (radium-223 dichloride)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Prostate Adenocarcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-04-09